Next Article in Journal
Lactobacillus rhamnosus GG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy
Previous Article in Journal
An 8-Week Ketogenic Diet Alternated Interleukin-6, Ketolytic and Lipolytic Gene Expression, and Enhanced Exercise Capacity in Mice
Open AccessArticle

A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy

1
Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
2
School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
3
Pediatric Cardiology Clinic, Taichung 40244, Taiwan
4
Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
5
Graduate Program in Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan
6
Department of Nutrition, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(11), 1697; https://doi.org/10.3390/nu10111697
Received: 29 September 2018 / Revised: 25 October 2018 / Accepted: 5 November 2018 / Published: 7 November 2018
Background: Pediatric dilated cardiomyopathy (PDCM) is a life-threatening type of cardiac muscle dysfunction in children. Ubiquinone is a lipid-soluble nutrient that participates in energy synthesis. Recently, a novel hydrophilic ubiquinol supplement was developed. The purpose of this study was to assess the effect of liquid ubiquinol supplementation (10 mg/kg body weight/day) on cardiac function in children with PDCM. Methods: Ten children diagnosed with PDCM were recruited to this study and administered with liquid ubiquinol for 24 weeks. The cardiac function was measured by echocardiography. The New York Heart Association (NYHA) functional classification was used to assess symptoms of heart failure. Plasma coenzyme Q10 levels were measured during the study. Results: Ejection fraction (EF) and fractional shortening (FS) were significantly higher than the baseline values until week 16 of supplementation. Subjects who had higher plasma coenzyme Q10 concentration had significantly better EF and FS values. In addition, 30% of the subjects showed improvement in the NYHA classification after 24 weeks of supplementation. Conclusion: Liquid ubiquinol supplementation is associated with an increase the level of coenzyme Q10 to complementary improve cardiac function (particularly EF and FS) and ameliorate the symptoms of heart failure in children with PDCM. View Full-Text
Keywords: liquid ubiquinol; coenzyme Q10; pediatric dilated cardiomyopathy; heart failure; pediatric nutrition; dietary supplementation liquid ubiquinol; coenzyme Q10; pediatric dilated cardiomyopathy; heart failure; pediatric nutrition; dietary supplementation
Show Figures

Figure 1

MDPI and ACS Style

Chen, F.-L.; Chang, P.-S.; Lin, Y.-C.; Lin, P.-T. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy. Nutrients 2018, 10, 1697. https://doi.org/10.3390/nu10111697

AMA Style

Chen F-L, Chang P-S, Lin Y-C, Lin P-T. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy. Nutrients. 2018; 10(11):1697. https://doi.org/10.3390/nu10111697

Chicago/Turabian Style

Chen, Fong-Lin; Chang, Po-Sheng; Lin, Yi-Chin; Lin, Ping-Ting. 2018. "A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy" Nutrients 10, no. 11: 1697. https://doi.org/10.3390/nu10111697

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop